Table 2.
Groups | ADC values of tumor (×10−3mm2/s) |
||
---|---|---|---|
7d | 14d | 21d | |
TMZ+AAV2-VEGF-Trap | 1.02 ± 0.11 | 1.35 ± 0.18** | 1.46 ± 0.19** |
TMZ+BEV | 0.93 ± 0.19 | 1.31 ± 0.13** | 1.38 ± 0.10** |
TMZ | 0.93 ± 0.14 | 1.02 ± 0.14* | 1.16 ± 0.21* |
AAV2-VEGF-Trap | 1.06 ± 0.14 | 1.16 ± 0.12* | 1.17 ± 0.13* |
BEV | 1.04 ± 0.18 | 1.15 ± 0.20* | 1.19 ± 0.18* |
Control | 1.07 ± 0.14 | 0.85 ± 0.13 | 0.74 ± 0.13 |
Abbreviations: TMZ, temozolomide; AAV2-VEGF-Trap, adeno-associated virus 2 mediated gene transfer of vascular endothelial growth factor Trap; BEV, bevacizumab.
P values:
**: TMZ+AAV2-VEGF-Trap group and TMZ+BEV group vs. control group, <0.05;
*: TMZ group, AAV2-VEGF-Trap group and BEV group vs. control group, >0.05.